Latin America

Digestive remedies continued to see an expansion in its consumer base in 2023 with higher penetration levels translating to stronger retail value sales. Products for indigestion and heartburn saw healthy growth thanks to more consumers eating outside…

Digestive remedies has been amongst the most dynamic categories within OTC. With people back to their normal routines, which include an increase in the frequency of eating out of the home, they have been more prone to suffer from bloating, reflux, or…

Digestive remedies in Chile is experiencing a deceleration in value growth during 2023 compared to the double-digit increases observed in the previous two years. Despite a general decline in demand, the category continues to show healthy growth rates…

The increased availability of low-cost generic proton pump inhibitors containing compounds such as omeprazole are dampening volume sales of antacids. Despite omeprazole being registered as an Rx drug, it is widely available, and can be accessed…

Retail sales of digestive remedies saw accelerated growth in constant value terms in 2023, as consumers returned to their busy, pre-pandemic lifestyles. With fears over the COVID-19 pandemic beginning to subside, there was notable increase in the…

Probiotic supplements is a standout product within dietary supplements and is expected to register double-digit volume growth in 2023. Probiotics supplements are available over the counter, but part of their success is due to sales representatives…

Dietary supplements continues to expand in 2023 as consumers have a large variety of products to choose from and are responding favourably to new product launches. At the end of 2022, for instance, Megalabs, launched InvitaEnergy, a combination of…

The dietary supplements category is expected to experience positive growth rates in 2023, largely driven by prices, although the growth is expected to be slower than that seen previously in the review period. Despite the increasing concern amongst…

Dietary supplements in Chile is experiencing a resurgence in dynamic value growth in 2023, following a decline the previous year. This renewed growth can be attributed to the growing interest among consumers in educating themselves about the…

While dietary supplements are expected to register moderate current value growth, constant value growth is expected to be minimal. Dietary supplements are mainly imported and in 2023 costs have been rising for imports, due to a sharp decline in…

Despite ongoing economic instability, consumers remained keen to maintain healthy lifestyles in order to help boost their immune systems. This, alongside the expansion of health food shops, boosted retail volume sales of dietary supplements in 2023.…

Medicated shampoo is expected to register the highest current value growth in dermatologicals in 2023, with the big winner being Genommalab’s Medicasp. This brand has significantly increased value share over the review period. With substantial…

Despite the challenging economic conditions affecting the country, consumers continue to purchase a variety of dermatological products as awareness about treating certain conditions increases. Categories such as haemorrhoid treatments, medicated…

Dermatologicals is expected to see higher value growth in 2023 than in the previous year. Value growth is partly being driven by escalating prices and partly by people returning to in-person medical consultations, which lead to more recommendations…

Dermatologicals maintain a healthy growth trajectory in line with figures recorded in 2022, retaining significant value sales that surpass pre-pandemic levels. While this category typically demonstrates notable stability and does not exhibit…

With society operating normally once again, after the pandemic, visits to doctors in relation to skin conditions have increased. This is seeing products such as topical antifungals, vaginal antifungals, cold sore treatments, and haemorrhoid…

Retail sales of dermatologicals saw a second year of healthy growth in constant value terms in 2023. The category suffered a decline during the pandemic, when consumers spent more time at home and were therefore less exposed to environments which…

Cough, cold and allergy (hay fever) remedies are expected to register a decline in value sales. Value sales are now at more normal levels, as concerns about the COVID-19 virus have abated. In addition, Ecuador is grappling with rising crime rates and…

Cough, cold and allergy (hay fever) remedies are among the most popular consumer health items in the Dominican Republic and are experiencing further growth in 2023 despite higher unit prices resulting largely from persistent inflationary pressures…

In 2022, demand for cold, cough and allergy (have fever) remedies soared, as a result of the atypical increase in flu cases, as social distancing, handwashing protocols, and the use of face masks were totally lifted in 2022, facilitating the spread…